Department of Applied Sciences Indian Institute of Information Technology Allahabad Prayagraj Uttar Pradesh India

Department of Physics Deen Dayal Upadhyaya Gorakhpur University Gorakhpur India

Laboratory of Ligand Engineering Institute of Biotechnology of the Czech Academy of Sciences v v i BIOCEV Research Center Vestec Czech Republic

Editorial on the Research Topic Advances in the therapeutic targeting of human matrix metalloproteinases in health and disease PubMed

Zobrazit více v PubMed

Alexdottir M. S., Bourgonje A. R., Karsdal M. A., Pehrsson M., Loveikyte R., Van Dullemen H. M., et al. (2022). Serological biomarkers of intestinal collagen turnover identify early response to infliximab therapy in patients with Crohn's disease. Front. Med. (Lausanne) 9, 933872. 10.3389/fmed.2022.933872 PubMed DOI PMC

Biancheri P., Brezski R. J., Di Sabatino A., Greenplate A. R., Soring K. L., Corazza G. R., et al. (2015). Proteolytic cleavage and loss of function of biologic agents that neutralize tumor necrosis factor in the mucosa of patients with inflammatory bowel disease. Gastroenterology 149, 1564–1574. 10.1053/j.gastro.2015.07.002 PubMed DOI

Cao Y., Harvey B. P., Hong F., Ruzek M., Wang J., Murphy E. R., et al. (2021). Adalimumab induces a wound healing profile in patients with hidradenitis suppurativa by regulating macrophage differentiation and matrix metalloproteinase expression. J. Invest Dermatol 141, 2730–2740. 10.1016/j.jid.2021.04.010 PubMed DOI

Chang C., Werb Z. (2001). The many faces of metalloproteases: Cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol. 11, S37–S43. 10.1016/s0962-8924(01)02122-5 PubMed DOI PMC

Craig V. J., Zhang L., Hagood J. S., Owen C. A. (2015). Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 53, 585–600. 10.1165/rcmb.2015-0020TR PubMed DOI PMC

Cui N., Hu M., Khalil R. A. (2017). “Chapter one - biochemical and biological attributes of matrix metalloproteinases,” in Progress in molecular biology and translational science. Editor Khalil R. A. (Academic Press; ), 1–73. PubMed PMC

Fang X., Duan S. F., Hu Z. Y., Wang J. J., Qiu L., Wang F., et al. (2022). Inhibition of matrix metalloproteinase-8 protects against sepsis serum mediated leukocyte adhesion. Front. Med. (Lausanne) 9, 814890. 10.3389/fmed.2022.814890 PubMed DOI PMC

Garcia-Irigoyen O., Latasa M. U., Carotti S., Uriarte I., Elizalde M., Urtasun R., et al. (2015). Matrix metalloproteinase 10 contributes to hepatocarcinogenesis in a novel crosstalk with the stromal derived factor 1/C-X-C chemokine receptor 4 axis. Hepatology 62, 166–178. 10.1002/hep.27798 PubMed DOI

Georgiadis D., Yiotakis A. (2008). Specific targeting of metzincin family members with small-molecule inhibitors: Progress toward a multifarious challenge. Bioorg. Med. Chem. 16, 8781–8794. 10.1016/j.bmc.2008.08.058 PubMed DOI

Gialeli C., Theocharis A. D., Karamanos N. K. (2011). Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. Febs J. 278, 16–27. 10.1111/j.1742-4658.2010.07919.x PubMed DOI

Gobin E., Bagwell K., Wagner J., Mysona D., Sandirasegarane S., Smith N., et al. (2019). A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential. BMC Cancer 19, 581. 10.1186/s12885-019-5768-0 PubMed DOI PMC

Jacobsen J. A., Major Jourden J. L., Miller M. T., Cohen S. M. (2010). To bind zinc or not to bind zinc: An examination of innovative approaches to improved metalloproteinase inhibition. Biochim. Biophys. Acta 1803, 72–94. 10.1016/j.bbamcr.2009.08.006 PubMed DOI

Jiang H., Li H. (2021). Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: A systematic review and meta-analysis. BMC Cancer 21, 149. 10.1186/s12885-021-07860-2 PubMed DOI PMC

Khalil R. A. (2017). Matrix metalloproteinases and tissue remodeling in health and disease: Target tissues and therapy. Academic Press.

Laronha H., Caldeira J. (2020). Structure and function of human matrix metalloproteinases. Cells 9, 1076. 10.3390/cells9051076 PubMed DOI PMC

Laronha H., Carpinteiro I., Portugal J., Azul A., Polido M., Petrova K. T., et al. (2020). Challenges in matrix metalloproteinases inhibition. Biomolecules 10, 717. 10.3390/biom10050717 PubMed DOI PMC

Li K., Tay F. R., Yiu C. K. Y. (2020). The past, present and future perspectives of matrix metalloproteinase inhibitors. Pharmacol. Ther. 207, 107465. 10.1016/j.pharmthera.2019.107465 PubMed DOI

Loffek S., Schilling O., Franzke C. W. (2011). Series "matrix metalloproteinases in lung health and disease": Biological role of matrix metalloproteinases: A critical balance. Eur. Respir. J. 38, 191–208. 10.1183/09031936.00146510 PubMed DOI

Malemud C. J. (2006). Matrix metalloproteinases (MMPs) in health and disease: An overview. Front. Biosci. 11, 1696–1701. 10.2741/1915 PubMed DOI

Mortensen J. H., Lindholm M., Langholm L. L., Kjeldsen J., Bay-Jensen A. C., Karsdal M. A., et al. (2019). The intestinal tissue homeostasis ? The role of extracellular matrix remodeling in inflammatory bowel disease. Expert Rev. Gastroenterology Hepatology 13, 977–993. 10.1080/17474124.2019.1673729 PubMed DOI

Nam D. H., Rodriguez C., Remacle A. G., Strongin A. Y., Ge X. (2016). Active-site MMP-selective antibody inhibitors discovered from convex paratope synthetic libraries. Proc. Natl. Acad. Sci. U S A 113, 14970–14975. 10.1073/pnas.1609375114 PubMed DOI PMC

Page-Mccaw A., Ewald A. J., Werb Z. (2007). Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol. 8, 221–233. 10.1038/nrm2125 PubMed DOI PMC

Pehrsson M., Mortensen J. H., Manon-Jensen T., Bay-Jensen A. C., Karsdal M. A., Davies M. J. (2021). Enzymatic cross-linking of collagens in organ fibrosis - resolution and assessment. Expert Rev. Mol. Diagnostics 21, 1049–1064. 10.1080/14737159.2021.1962711 PubMed DOI

Santamaria S., De Groot R. (2019). Monoclonal antibodies against metzincin targets. Br. J. Pharmacol. 176, 52–66. 10.1111/bph.14186 PubMed DOI PMC

Swarnakar S., Paul S., Singh L. P., Reiter R. J. (2011). Matrix metalloproteinases in health and disease: Regulation by melatonin. J. Pineal Res. 50, 8–20. 10.1111/j.1600-079X.2010.00812.x PubMed DOI

Van Haaften W. T., Mortensen J. H., Dige A. K., Gronbaek H., Hvas C. L., Bay-Jensen A. C., et al. (2020). Serological biomarkers of tissue turnover identify responders to anti-TNF therapy in Crohn's disease: A pilot study. Clin. Transl. Gastroenterol. 11, e00217. 10.14309/ctg.0000000000000217 PubMed DOI PMC

Xie Y., Mustafa A., Yerzhan A., Merzhakupova D., Yerlan P., Wang X., et al. (2017). Nuclear matrix metalloproteinases: Functions resemble the evolution from the intracellular to the extracellular compartment. Cell Death Discov. 3, 17036. 10.1038/cddiscovery.2017.36 PubMed DOI PMC